Booster pneumonia vaccine for children who completed earlier series
Part of Infections clinical trials.
This study tests a booster dose of a 13-valent pneumonia vaccine (which protects against 13 types of pneumococcal bacteria) in children who already received the full series about 4 years ago in an earlier study. It aims to see if a booster helps maintain protection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child took part in the earlier study of this pneumonia vaccine when they were about 2 months old.
- At least 4 years have passed since the last dose of the vaccine series in that earlier study.
- You did not receive any other pneumonia vaccine after completing the full series.
- No current fever (temperature below 37.3°C / 99.1°F).
- A legal guardian or authorized representative must be willing to provide identification and sign a consent form.
- You must have completed the blood draws at 1 and 2 years after vaccination in the earlier study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new pneumonia vaccine (PCV13) in healthy infants to see if it works as well as a current vaccine. It compares the immune response and safety of the two vaccines.
This study tests a booster shot of a meningococcal vaccine (which protects against four types of meningitis) in children who already received the same type of vaccine years ago. The goal is to see if a booster can refresh and strengthen protection against these serious infections.
This trial tests a 13-valent pneumococcal conjugate vaccine to prevent pneumonia and serious infections caused by pneumococcus bacteria. It may be a good option if your child has never had a pneumococcal vaccine before.
This study tests a new pneumonia vaccine in healthy children to see if it is safe and works well. It may help protect your child from serious infections caused by the bacteria that lead to pneumonia.
This trial tests a new vaccine designed to protect against 24 types of pneumococcal bacteria (which cause pneumonia and other serious infections). Researchers are checking if it's safe and how well it works in infants, children, and adults.
This trial tests a new pneumococcal vaccine for babies around 2 months old. It aims to prevent serious infections like pneumonia and meningitis, and may offer protection against more strains than current vaccines.
Hear when a new Pneumococcal Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.